| Autor: |
Ng I; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia., Luk IY; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia., Nightingale R; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia., Reehorst CM; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia., Dávalos-Salas M; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; Department of Biochemistry, Monash University, Melbourne, Victoria, Australia., Jenkins LJ; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia., Fong C; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia., Williams DS; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia.; Department of Pathology, Austin Health, Melbourne, Victoria, Australia., Watt MJ; Department of Anatomy and Physiology, Faculty of Medicine Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia., Dhillon AS; Institute of Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia., Mariadason JM; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia. |
| Abstrakt: |
High-fat (HF) diets (HFDs) and inflammation are risk factors for colon cancer; however, the underlying mechanisms remain to be fully elucidated. The transcriptional corepressor HDAC3 has recently emerged as a key regulator of intestinal epithelial responses to diet and inflammation with intestinal-specific Hdac3 deletion ( Hdac3 IKO ) in mice increasing fatty acid oxidation genes and the rate of fatty acid oxidation in enterocytes. Hdac3 IKO mice are also predisposed to experimentally induced colitis; however, whether this is driven by the intestinal metabolic reprogramming and whether this predisposes these mice to intestinal tumorigenesis is unknown. Herein, we examined the effects of intestinal-specific Hdac3 deletion on colitis-associated intestinal tumorigenesis in mice fed a standard (STD) or HFD. Hdac3 IKO mice were highly prone to experimentally induced colitis, which was further enhanced by an HFD. Hdac3 deletion also accelerated intestinal tumor development, specifically when fed an HFD and most notably in the small intestine where lipid absorption is maximal. Expression of proteins involved in fatty acid metabolism and oxidation (SCD1, EHHADH) were elevated in the small intestine of Hdac3 IKO mice fed an HFD, and these mice displayed increased levels of lipid peroxidation, DNA damage, and apoptosis in their villi, as well as extensive expansion of the stem cell and progenitor cell compartment. These findings reveal a novel role for Hdac3 in suppressing colitis and intestinal tumorigenesis, particularly in the context of consumption of an HFD, and reveal a potential mechanism by which HFDs may increase intestinal tumorigenesis by increasing fatty acid oxidation, DNA damage, and intestinal epithelial cell turnover. NEW & NOTEWORTHY We reveal a novel role for the transcriptional corepressor Hdac3 in suppressing colitis and intestinal tumorigenesis, particularly in the context of consumption of an HFD, and reveal a potential mechanism by which HFDs may increase intestinal tumorigenesis by increasing fatty acid oxidation, DNA damage, and intestinal epithelial cell turnover. We also identify a unique mouse model for investigating the complex interplay between diet, metabolic reprogramming, and tumor predisposition in the intestinal epithelium. |
